Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

REGENXBIO INC.

Filed by DLA PIPER LLP (US).

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
Registration
Posted
Dec 15, 2025
Income
Not reported
Expenses
Not reported
Filing UUID
47d73da0-89b0-4d22-a0e2-94f1b8f4c6f6
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Issues related to rare disease.

MED · Medical/Disease Research/Clinical Labs

Issues related to rare disease.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.